Health-related Quality of Life Among Urinary Stone Patients in Central Jordan: A Cross-sectional Study Using SF-36
PDF
Cite
Share
Request
Original Research
E-PUB
13 October 2026

Health-related Quality of Life Among Urinary Stone Patients in Central Jordan: A Cross-sectional Study Using SF-36

J Urol Surg. Published online 13 October 2026.
1. Al-Balqa Applied University Faculty of Medicine Department of Urology, As-Salt, Jordan
No information available.
No information available
Received Date: 04.11.2025
Accepted Date: 14.12.2025
E-Pub Date: 13.10.2026
PDF
Cite
Share
Request

Abstract

Objective

This study evaluated health-related quality of life (HRQoL) among Jordanian patients with urolithiasis using the short form 36 health survey questionnaire (SF-36) and tested associations with demographic and clinical factors.

Materials and Methods

A cross-sectional survey of 288 adults attending As-Salt Hospital’s urology clinics between June 2024 and March 2025 was conducted using the validated Arabic SF-36. Consecutive patients attending urology clinics who were aged ≥18 years and had no psychiatric or chronic medical illnesses were approached. Clinical variables included stone size, location, number of procedures, and treatment modality. Multivariable linear regression identified independent predictors of SF-36 domains after adjustment for age, sex, marital status, and employment.

Results

Mean age 36.7±10.2 years; 67.4% male; 63.9% married. Physical functioning and social functioning had the highest domain mean scores (64.7 and 60.8, respectively). Energy/fatigue and general health had the lowest scores (50.6 and 51.9, respectively). In multivariable analysis, patients aged 18-29 years had higher physical functioning (β=29.65, p<0.001) and energy/fatigue scores (β=13.57, p<0.001) than those aged >50 years. Ureteric versus both kidney and ureter locations was not significantly associated with physical functioning (β=-6.78, p=0.121). Stones >1.3 cm versus ≤1.3 cm were associated with higher emotional role (β=20.07, p=0.003), social functioning (β=8.27, p=0.014), pain (β=7.65, p=0.023), and general health scores (β=3.28, p=0.041).

Conclusion

HRQoL among patients with urolithiasis in Jordan may be associated with age and stone burden. Gender and employment were associated with some domains. Findings emphasize the need for patient-centered management and early evaluation, but do not indicate causality due to the nature of this study.

Keywords:
Urolithiasis, quality of life, SF-36, Jordan, urinary stones

What’s known on the subject? and What does the study add?

Urinary stone disease can impair health related quality of life, but evidence from Jordan remains limited. This cross-sectional study assessed 288 patients in Central Jordan using the Arabic SF-36. Younger age was associated with higher scores in most domains. Stones >1.3 cm were associated with higher adjusted emotional role, social functioning, pain, and general health scores. Sex and employment status were associated with selected domains. These findings provide regional evidence to inform patient-centered care; the cross-sectional design does not establish causality.

Introduction

Urolithiasis, or urinary stone disease, is a common and recurrent condition with a lifetime prevalence ranging from 1% to 13%, depending on the population and geographical location (1). Over the past few decades, its global incidence has risen significantly, likely due to lifestyle and dietary changes (1, 2) Recurrence is a major concern, with studies estimating that 30-50% of patients experience another episode within ten years of their first episode (1).

Urinary stones can present with a range of clinical manifestations, from asymptomatic cases to acute ureteric colic and severe complications, such as infection and sepsis (3). Chronic stone formers often require repeated medical interventions, frequent follow-ups, and they may experience significant disruptions to their daily routines and overall well-being (3). Treatment options depend on the stone’s size, location, and symptom severity, and include conservative management, medical expulsive therapy, and various surgical interventions (4, 5).

Patients with symptomatic stones report significantly higher levels of stress, anxiety, and depression than the general population (6). Furthermore, many affected individuals are of working age, and time away from employment due to stone episodes can impose substantial economic strain on individuals, their families, and society (7).

Studies have shown that more frequent stone episodes correlate with greater impairment in health-related quality of life (HRQoL), while preventive strategies can improve patient outcomes (8). Factors such as distance to healthcare facilities, travel burden, and delays in accessing care can further worsen HRQoL (9). In addition, socio-economic disparities play a significant role, with patients from low-income or minority backgrounds experiencing disproportionately worse QoL outcomes (10).

Several variables have been identified as key predictors of QoL in stone patients. These include age, body mass index, number of surgical interventions, sleep quality, and even work environment (11, 12). This study aims to examine the psychosocial and functional implications of urolithiasis.

Materials and Methods

This cross-sectional, clinic-based survey was conducted at the Urology Department of As-Salt Hospital, Balqa Governorate, Jordan, from June 2024 to March 2025. Consecutive patients attending routine follow-up or pre-operative consultations were approached during outpatient hours.

Adults aged ≥18 years with radiologically confirmed urinary stones who were managed for urolithiasis for at least one episode during the preceding year and whose native language was Arabic were included. This study excluded patients with cognitive or psychiatric impairment, active infection, pregnancy, chronic medical illnesses such as chronic kidney disease, diabetes mellitus, and hypertension requiring pharmacologic treatment, chronic pain syndromes, neoplastic disease, neurologic disorders, or patients who refused to participate.

We applied the exclusion criteria mentioned because of the well-known impact of medical comorbidities on generic QoL measures such as short form 36 health survey questionnaire (SF-36), which we used in this study.

A minimum sample size of 250 participants was estimated using G*Power (α=0.05, power=0.80) to detect a moderate effect size (f2=0.10) in a multivariate regression with eight predictors. Allowing for a 10% non-response, 300 patients were targeted. The final analytic sample was 288, representing a 96% response rate over the study period.

Socio-demographic variables included age, sex, marital status, educational level, and employment. Data about stone size (cm) and location (kidney vs. ureter) were abstracted from imaging reports (computed tomography or ultrasound). Stone size was defined as the largest diameter measured radiographically. We collected data on the history and frequency of interventions, such as ureteroscopy (URS), retrograde intrarenal surgery (RIRS), shock wave lithotripsy (SWL), or percutaneous nephrolithotomy (PNL), if any had been performed in the last 12 months.

The SF-36 consists of 36 items assessing eight QoL domains: physical functioning (PF), role limitations/physical, pain, general health (GH), vitality (VT; energy and fatigue), social functioning (SF), role limitations/emotional, and mental health (MH; emotional well-being). The validated Arabic version of the SF-36 (13) was used; domain scores were computed on a 0-100 scale, with higher scores indicating better HRQoL.

We acknowledge that disease-specific instruments, such as the Wisconsin Stone QoL (WISQoL) questionnaires, demonstrate greater sensitivity in detecting urolithiasis-related symptoms. However, the choice of the SF-36 in this study was driven by both feasibility and methodological considerations.

The SF-36 is concise and provides a relatively low respondent burden, making it suitable for routine use in fast-paced clinical settings.

Importantly, the SF-36 has been validated locally and has a well-established psychometric profile. Its prior use in urolithiasis cohorts supports its ability to detect meaningful differences in the general physical and mental health of stone patients, even though it does not evaluate stone-specific symptom domains.

We asked all participants in this research to provide informed consent before completing the questionnaire. We did not collect personally identifiable data to ensure patient privacy and confidentiality.

The study adhered to the ethical principles outlined in the Declaration of Helsinki. Ethical approval has been sought from the Al-Balqa Applied University, Institutional Review Board at the Faculty of Medicine to ensure that all ethical standards are met throughout the research process (approval no: B.A.T 37/2024, date: 17.07.2024).

Statistical Analysis

Analyses were performed using IBM SPSS Statistics, version 28.0 (IBM Corp., Armonk, NY, USA). Descriptive statistics summarize demographic and clinical characteristics. SF-36 items were scored following the standard scoring system, including recoding of negatively oriented items and linear transformation of all domains to a 0-100 scale. Descriptive statistics are presented as mean ± standard deviation (SD) to ensure comparability with existing SF-36 literature. Because SF-36 scores were non-normally distributed, non-parametric tests were used.

Continuous outcomes from the SF-36 quality-of-life domains were summarized using means and SDs. Comparisons between two independent groups (e.g., gender: male vs. female; marital status: married vs. not married; employment status: employed vs. unemployed) were performed using the Wilcoxon rank-sum test (Mann-Whitney U test). For each group comparison, mean SD values for the SF-36 domains are reported for descriptive purposes, and two-tailed p-values from the Mann-Whitney U test are reported to assess statistical significance. Kruskal-Wallis tests were used for three-group comparisons. A p-value <0.05 was considered statistically significant.

Multivariable linear regression analyses were performed with each SF-36 domain as the dependent variable. Independent variables included age, stone size (cm), number of procedures, and treatment modalities (medical expulsive therapy, semirigid URS, RIRS), all entered simultaneously. Age was modeled as an approximately continuous variable using the midpoints of predefined age groups. Treatment variables were coded as binary indicators (1=received, 0=not received). Regression coefficients (β) and corresponding p-values were reported, with p<0.05 considered statistically significant.

Selection of the appropriate model followed a clinical-hierarchical approach: all relevant clinical variables, and those with p<0.15 in univariate screening, were entered into the initial multivariable model. We retained variables that were statistically significant or whose removal changed any β coefficient by ≥10%. Model assumptions were evaluated using residual plots, Q-Q plots, Shapiro-Wilk tests, and tests for homoscedasticity. Collinearity was examined using variance inflation factors; all were <5. We summarized model performance using R2 and adjusted R2. Regression coefficients (β), 95% confidence intervals, and p-values are reported for all predictors.

Potential confounders were determined based on clinical relevance, priority, and data from previous research on factors that may affect the severity of stone disease and health-related quality of life. This included factors such as age, stone size, selected treatment modality, and frequency of previous procedures. All treatment modalities were coded as binary variables (yes/no). Every SF-36 domain was modelled separately, using a fully adjusted multivariable linear regression model to estimate the independent effect of each domain on HRQoL, while we kept the other covariates constant.

Results

A total of 288 patients completed the survey (response rate=96%). The mean age was 36.7±10.2 years (range 18-65). Most participants were male (67.4%), married (63.9%), and employed (71.5%). Fifty-two point eight percent had stones 6 1.3 cm; 39.9% were in the kidney and 34.7% in the ureter. Approximately 50% underwent more than one procedure. The most frequent intervention was shockwave lithotripsy (48.3%), followed by semirigid URS (32%), and RIRS (29%) (Table 1).

Mean SF-36 domain scores (SD) were physical functioning 64.72 (±25.63), role limitations due to physical health 52.17 (±37.82), pain 59.29 (±23.80), general health 51.89 (±9.90), energy/fatigue 50.59 (±17.11), social functioning 60.76 (±21.29), role limitations due to emotional problems 54.75 (±41.84), and emotional well-being 55.43 (±17.04). Energy/fatigue and general health had the lowest mean domain scores. The separate health-change item had a mean score of 52.69 (±22.07).

Significant differences in SF-36 domain scores were observed based on gender, marital status, and employment status. Female patients reported better QoL than males, with higher scores in PF (69.6 vs. 62.4, p=0.014) (Table 2), energy/fatigue (54.8 vs. 48.5, p=0.011), emotional well-being (58.8 vs. 53.8, p=0.021), SF (65.7 vs. 58.4, p=0.005), pain (67.9 vs. 55.1, p<0.001), GH (54.6 vs. 50.6, p<0.001), and health change (57.2 vs. 50.5, p=0.041). Marital status was also associated with significant differences: unmarried participants scored higher than married participants in PF (70.2 vs. 61.6, p=0.001); role limitations due to physical health (60.1 vs. 47.7, p=0.006); energy/fatigue (55.2 vs. 48.0, p<0.001); emotional well-being (58.1 vs. 53.9, p=0.024); SF (68.2 vs. 56.6, p<0.001); pain (70.9 vs. 52.7, p<0.001); GH (54.5 vs. 50.4, p<0.001); and health change (59.1 vs. 49.1, p<0.001). Employment status was significantly associated only with the pain domain; unemployed individuals reported higher scores than employed participants (64.3 vs. 57.3; p=0.037), indicating less pain (Table 2).

Significant differences in SF-36 scores were observed based on stone size and the use of medical expulsive therapy. Participants with stones >1.3 cm appeared to have higher scores in PF (p=0.035) (Table 3), role limitations due to physical health (p=0.003), emotional problems (p<0.001), SF (p=0.001), and pain (p=0.008), compared to those with larger stones. Similarly, patients who did not receive medical expulsive therapy reported higher scores on measures of PF (p=0.017), role limitations due to physical health (p<0.001), emotional problems (p<0.001), SF (p=0.020), and emotional well-being (p=0.030). No significant differences were observed in SF-36 domains associated with semirigid URS (Table 3).

RIRS and stone location were significantly associated with variations in SF-36 scores. Patients who underwent RIRS reported higher scores on role limitations due to physical health (p=0.043) (Table 4), emotional problems (p=0.023), and SF (p=0.039) compared with those who did not undergo RIRS. Stone location also influenced PF (p=0.022), with the highest scores observed in patients with stones in both the kidney and the ureter. Role limitations due to physical health (p=0.018) and emotional problems (p=0.006) also varied significantly by stone location. The number of procedures was not significantly associated with any SF-36 domain (Table 4).

Age and education level were significantly associated with variations in SF-36 scores. SF differed notably across age groups (p<0.001) (Table 5), with the highest scores reported among participants aged 18-29 (75.4%), followed by those aged 30-39 (63.3%). Educational level also influenced SF (p<0.001), with the highest value observed among university-educated individuals (69.3%). Pain scores varied significantly by age (p=0.006) and education (p<0.001), with better scores in younger participants and those with higher education. Role limitations due to emotional problems differed by educational level (p=0.039), with university graduates reporting the highest scores. PF, role limitations due to physical health, energy/fatigue, emotional well-being, and GH varied significantly by age and education (p<0.001), with younger and more educated individuals reporting better outcomes.

Multivariate linear regression identified age and stone size as significantly associated with several SF-36 domains. Compared with participants over 50, those aged 18-29 had significantly higher scores in PF (p<0.001, β=29.6), role limitations due to physical health (p=0.001, β=34.6), and energy/fatigue (p<0.001, β=13.6). Also, they scored better in the rest of QoL domains, and this was significant for all domains except GH. The 30-39 age group also showed higher PF (p<0.001, β=20.8), higher physical role scores (p=0.006, β=19.3), higher energy and fatigue scores (p=0.006, β=8.6), and reported less pain (p<0.001, β=20.1). Stones >1.3 cm were associated with better scores for emotional role limitation (p=0.003, β=20), pain (p=0.02, β=7.65), SF (p=0.01, β=8.27), and GH (p=0.04, β=3.28). Male patients had more pain, less energy, greater fatigue, and poorer GH compared with female patients. Unemployed participants scored poorly on measures of PF and GH (Tables 6 and 7).

The choice of procedure does not significantly affect most domains of postoperative quality of life in patients with renal stones, excluding ureteric stones. Regardless of whether patients underwent SWL, RIRS, or PNL, and after adjusting for age, gender, and stone size, general recovery and perceived well-being were broadly similar across physical, emotional, and social domains. Patients managed with RIRS or PNL reported higher GH scores than patients treated with SWL. After adjustment for age, gender, and stone size, URS does not significantly improve or worsen the SF-36 quality-of-life scores compared with medical expulsive therapy among patients with ureteric stones. Ureteric stones were associated with lower scores in PF, physical role limitations, energy and fatigue, and emotional domains, but none of these associations was statistically significant. No significant associations were found with marital status. Other factors did not demonstrate statistically significant associations.

Discussion

This study provides new evidence on the global HRQoL of patients with urinary stones in Jordan, assessed using the SF-36 instrument.

Our updated results emphasize that younger patients consistently reported better QoL scores, particularly in PF, energy, and emotional well-being. In contrast, patients older than 50 years reported lower scores across most domains, and these findings were consistent with previous studies showing that age is an important predictor of the physical and psychological impact of urinary stone disease (14, 15). These findings might be explained by greater physiological resilience and a short duration of symptoms before diagnosis. On the other hand, older patients may experience long-standing comorbidities and treatment delays.

Gender-based differences were also observed: our findings indicated that women had better outcomes than men in several quality-of-life domains, including pain, energy, fatigue, and GH. Although previous literature usually links women with higher levels of pain and emotional distress (16-18), our findings suggest that social factors, such as strong social support and a supportive culture may reduce the disease burden in this context.

This study also showed that married individuals scored significantly worse in the domains of pain, physical health, and GH. These findings may be surprising, since marriage is generally expected to provide greater emotional and social support. We may attribute these findings to the added stress of caregiving, financial strain, or social responsibilities, which are usually greater in married patients. However, marital status was not found to be an independent predictor of quality of life when it was tested in the multivariable regression model, suggesting that those early observations might have been influenced by other factors, such as age and gender (8, 19).

Existing evidence indicates that the level of education and improved access to information enable patients to seek medical care earlier, manage symptoms more efficiently, and maintain a better lifestyle. In our study, patients with a higher level of education consistently reported better scores across most physical and emotional domains (20, 21).

Stone-related factors, such as size and location, also had a notable impact on overall quality of life. Patients with ureteric stones reported lower scores in PF, emotional health, and role limitations. Patients with stone sizes less than 1.3 cm reported more pain, lower SF, and poorer GH. These findings contradicted the previously known link between larger stone size and reduced HRQoL (14, 15). This contradiction might be attributed to factors such as the short duration of this study, but it can also be explained by the fact that patients with larger stones may have benefited from more definitive treatments, including new minimally invasive technologies such as RIRS and highpower laser technology, which reduce the need for multiple procedures and are often associated with less postoperative pain.

Previous studies have shown that early intervention, especially medical expulsive therapy or URS for patients with ureteric stones, is associated with better QoL, highlighting the value of timely, minimally invasive treatment (8, 16). However, this cross-sectional study did not show a significant impact of URS or medical expulsive therapy on QoL.

RIRS also appeared to reduce limitations in both physical and emotional roles compared with those who did not undergo this procedure. This supports the increasing use of RIRS in modern urology because it offers a favorable balance between efficacy and invasiveness (8).

Employment can be associated with the physical and mental strain of maintaining work responsibilities while coping with a painful condition such as urolithiasis (22, 23). However, we did not find a strong association in this study.

Study Limitations

This study is limited by its single-center design. Its cross-sectional nature prevents long-term assessment. The sample size may not fully represent all patient groups. The exclusion of patients with medical comorbidities limits the generalizability of our findings to more medically complex populations with urinary stones. Our future plans will focus on evaluating QoL outcomes in larger, comorbidity-inclusive cohorts using disease-specific instruments and multivariable adjustment strategies. The exclusion of patients with mental health conditions underestimates the psychological burden. Additionally, using a generic QoL tool like SF-36 instead of a disease-specific measure limits condition-specific insight. Self-reported measures may introduce recall bias.

Although this study, utilizing a general tool, provides insight into the situation in the local population and may help provide a better initial understanding, we still need to conduct a multicenter study with broader representation and longitudinal follow-up to assess long-term impacts. Disease-specific QoL tools, such as WISQoL, provide more precise insights. The study’s cross-sectional design precludes causal inferences.

Conclusion

This study highlights the significant and multifactorial impact of urinary stones on patients’ quality of life. Age and stone characteristics play an important role in shaping physical and emotional well-being. Our findings reinforce the importance of individualized, patient-centered management approaches, particularly for older adults, patients with large or ureteric stones, and those without access to early intervention. Understanding these factors can guide clinicians in optimizing care and improving outcomes for patients with this common yet burdensome condition.

Ethics

Ethics Committee Approval: The study adhered to the ethical principles outlined in the Declaration of Helsinki. Ethical approval has been sought from the Al-Balqa Applied University, Institutional Review Board at the Faculty of Medicine to ensure that all ethical standards are met throughout the research process (approval no: B.A.T 37/2024, date: 17.07.2024).
Informed Consent: We asked all participants in this research to provide informed consent before completing the questionnaire. We did not collect personally identifiable data to ensure patient privacy and confidentiality.

Acknowledgments

We would like to express our sincere thanks to medical students: Ghufran Bani Amer, Aseel Abu Atieh, Meera Jaber, Yasmeen Alsakhen, Yazeed Awamleh, Aya Wishah, Mahmoud Gharaibeh, Alaa Alsoud, and Khaled Shawabkeh, who assisted with data collection.

Authorship Contributions

Surgical and Medical Practices: H.F., S.A., A.A., Concept: H.F., Design: H.F., S.A., Data Collection or Processing: H.F., S.A., A.A., Analysis or Interpretation: H.F., S.A., A.A., Literature Search: H.F., S.A., A.A., Writing: H.F., S.A.
Conflict of Interest: No conflict of interest was declared by the authors.
Financial Disclosure: The authors declared that this study received no financial support.

References

1
Alelign T, Petros B. Kidney stone disease: an update on current concepts. Adv Urol. 2018;2018:3068365.
2
Zeng G, Mai Z, Xia S, Wang Z, Zhang K, Wang L, Long Y, Ma J, Li Y, Wan SP, Wu W, Liu Y, Cui Z, Zhao Z, Qin J, Zeng T, Liu Y, Duan X, Mai X, Yang Z, Kong Z, Zhang T, Cai C, Shao Y, Yue Z, Li S, Ding J, Tang S, Ye Z. Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int. 2017;120:109-116.
3
Raja A, Wood F, Joshi HB. The impact of urinary stone disease and their treatment on patients’ quality of life: a qualitative study. Urolithiasis. 2020;48:227-234.
4
Al-Ansari A, As-Sadiq K, Al-Said S, Younis N, Jaleel OA, Shokeir AA. Prognostic factors of success of extracorporeal shock wave lithotripsy (ESWL) in the treatment of renal stones. Int Urol Nephrol. 2006;38:63-67.
5
Bao Y, Tu X, Wei Q. Water for preventing urinary stones. Cochrane Database Syst Rev. 2020;2:CD004292.
6
Miyaoka R, Ortiz-Alvarado O, Kriedberg C, Alanee S, Chotikawanich E, Monga M. Correlation between stress and kidney stone disease. J Endourol. 2012;26:551-555.
7
Linder BJ, Rangel LJ, Krambeck AE. The effect of work location on urolithiasis in health care professionals. Urolithiasis. 2013;41:327-331.
8
Patel N, Brown RD, Sarkissian C, De S, Monga M. Quality of life and urolithiasis: the patient - reported outcomes measurement information system (PROMIS). Int Braz J Urol. 2017;43:880-886.
9
Narang GL, Wiener LE, Penniston KL, Antonelli JA, Averch TD, Sivalingam S, Chew BH, Bird VG, Pais VM Jr, Sur RL, Chi T, Streeper NM, Nakada SY, Koch GG, Viprakasit DP. The effect of travel distance on health-related quality of life for patients with nephrolithiasis. Can Urol Assoc J. 2020;14:99-104.
10
Ahmad TR, Tzou DT, Usawachintachit M, Reliford-Titus S, Wu C, Goodman J, Antonelli JA, Viprakasit DP, Averch TD, Sivalingam S, Chew BH, Bird VG, Pais VM Jr, Streeper NM, Sur RL, Nakada SY, Penniston KL, Chi T. Low income and nonwhite race are strongly associated with worse quality of life in patients with nephrolithiasis. J Urol. 2019;202:119-124.
11
Wang S, Zhou X, Qiu S, Cai B, Li Y, Zhang C, Wang K, Yang L, Chen L. Association between sleep quality and urolithiasis among general population in Western China: a cross-sectional study. BMC Public Health. 2022;22:1787.
12
Stern KL, Gao T, Antonelli JA, Viprakasit DP, Averch TD, Chi T, Chew BH, Bird VG, Pais VM Jr, Streeper NM, Sur RL, Nakada SY, Penniston KL, Sivalingam S. Association of patient age and gender with kidney stone related quality of life. J Urol. 2019;202:309-313.
13
Khader S, Hourani MM, Al-Akour N. Normative data and psychometric properties of short form 36 health survey (SF-36, version 1.0) in the population of north Jordan. East Mediterr Health J. 2011;17:368-374.
14
Vo AK, Somani BK, Ulvik Ø, Beisland C, Seitz C, Juliebø-Jones P. Measuring quality of life in patients with kidney stone disease: is it the future in endourology? Curr Opin Urol. 2024;34:91-97.
15
New F, Somani BK. A complete world literature review of quality of life (QOL) in patients with kidney stone disease (KSD). Curr Urol Rep. 2016;17:88.
16
Joshi HB, Johnson H, Pietropaolo A, Raja A, Joyce AD, Somani B, Philip J, Biyani CS, Pickles T. Urinary Stones and Intervention Quality of Life (USIQoL): Development and validation of a new core universal patient-reported outcome measure for urinary calculi. Eur Urol Focus. 2022;8:283-290.
17
Raizenne BL, Deyirmendjian C, Lafontaine ML, Balde M, Bechis SK, Sur RL, Nakada SY, Antonelli JA, Streeper NM, Sivalingam S, Viprakasit DP, Averch TD, Landman J, Chi T, Pais VM, Chew BH, Bird VG, Andonian S, Canvasser NE, Harper JD, Penniston KL, Bhojani N. The impact of bilateral stone disease on patients’ disease progression and health-related quality of life. J Endourol. 2023;37:1289-1294.
18
Forbes CM, Bonnet K, Bryant T, Schlundt DG, Cavanaugh KL, Hsi RS. Decision-making and improvements in health-related quality of life in patients with kidney stones: comparing surgery versus observation using a mixed methods analysis. Urolithiasis. 2022;50:567-576.
19
Lee N, Nadeau P, Berjaoui MB, Assad A, Chew B, Penniston K, Bhojani N. Treatment modalities for small-sized urolithiases and their impact on health-related quality of life. Can Urol Assoc J. 2024;18:280-287.
20
Tapiero S, Limfuco L, Bechis SK, Sur RL, Penniston KL, Nakada SY, Antonelli JA, Streeper NM, Sivalingam S, Viprakasit DP, Averch TD, Okhunov Z, Patel RM, Chi T, Pais VM Jr, Chew BH, Bird VG, Andonian S, Bhojani N, Canvasser NE, Landman J. The impact of the number of lifetime stone events on quality of life: results from the North American Stone Quality of Life Consortium. Urolithiasis. 2021;49:321-326.
21
Arafa MA, Rabah DM. Study of quality of life and its determinants in patients after urinary stone fragmentation. Health Qual Life Outcomes. 2010;8:119.
22
Wang M, Lai CH, Ji J, Hu H, Ni R, Liu J, Yu L, Hu H. Association of health-related quality of life with urinary tract infection among kidney stone formers. Urolithiasis. 2024;52:103.
23
Penniston KL, Antonelli JA, Viprakasit DP, Averch TD, Sivalingam S, Sur RL, Pais VM Jr, Chew BH, Bird VG, Nakada SY. Validation and reliability of the Wisconsin Stone Quality of Life Questionnaire. J Urol. 2017;197:1280-1288.